Alaunos Therapeutics, Inc. (TCRT)

Price & Market Data

Price: $2.56

Daily Change: +$0.19 / 7.42%

Daily Range: $2.37 - $2.56

Market Cap: $5,909,993

Daily Volume: 15,097

Performance Metrics

1 Week: -6.17%

1 Month: -13.91%

3 Months: -5.43%

6 Months: -29.97%

1 Year: -5.06%

YTD: -26.77%

About Alaunos Therapeutics, Inc. (TCRT)

Summarized market data for Alaunos Therapeutics, Inc. (TCRT). Price: 2.56, daily change: +$0.19 / 7.42%. Market cap: 5,909,993. Performance over 3-month and 6-month periods.

Company Details

Employees: 1

Sector: Health technology

Industry: Biotechnology

Country: United States

Details

Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops small molecules to treat obesity and other metabolic disorders. The company develops an oral obesity compound that addresses shortcomings of injectable GLP-1 receptor agonists, including preserving lean muscle mass. It also evaluates ALN1001 and related derivatives on lipid deposition and gene expression. In addition, the company develops hunTR TCR discovery platform to target driver mutations. Alaunos Therapeutics, Inc. was founded in 2003 and is headquartered in Houston, Texas.

Selected stocks

Beyond Meat, Inc. (BYND)

U-BX Technology Ltd. (UBXG)

Montauk Renewables, Inc. (MNTK)

Autolus Therapeutics plc (AUTL)

Sharps Technology Inc. (STSS)